Price P - Search Results

1

Assessment of proliferation in vivo using 2-[(11)C]thymidine positron emission tomography in advanced intra-abdominal malignancies.

Wells P, Gunn RN, Alison M, Steel C, Golding M, Ranicar AS, Brady F, Osman S, Jones T, Price P. Wells P, et al. Among authors: price p. Cancer Res. 2002 Oct 15;62(20):5698-702. Cancer Res. 2002. PMID: 12384527 Clinical Trial.

2

2-[11C]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337.

Wells P, Aboagye E, Gunn RN, Osman S, Boddy AV, Taylor GA, Rafi I, Hughes AN, Calvert AH, Price PM, Newell DR. Wells P, et al. Among authors: price pm. J Natl Cancer Inst. 2003 May 7;95(9):675-82. doi: 10.1093/jnci/95.9.675. J Natl Cancer Inst. 2003. PMID: 12734319

3

3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.

Barthel H, Cleij MC, Collingridge DR, Hutchinson OC, Osman S, He Q, Luthra SK, Brady F, Price PM, Aboagye EO. Barthel H, et al. Cancer Res. 2003 Jul 1;63(13):3791-8. Cancer Res. 2003. PMID: 12839975

4

The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.

Collingridge DR, Carroll VA, Glaser M, Aboagye EO, Osman S, Hutchinson OC, Barthel H, Luthra SK, Brady F, Bicknell R, Price P, Harris AL. Collingridge DR, et al. Among authors: price p. Cancer Res. 2002 Oct 15;62(20):5912-9. Cancer Res. 2002. PMID: 12384557

5

Metabolic activation of temozolomide measured in vivo using positron emission tomography.

Saleem A, Brown GD, Brady F, Aboagye EO, Osman S, Luthra SK, Ranicar AS, Brock CS, Stevens MF, Newlands E, Jones T, Price P. Saleem A, et al. Among authors: price p. Cancer Res. 2003 May 15;63(10):2409-15. Cancer Res. 2003. PMID: 12750260

6

Assessment of inter- and intrapatient variability in C15O2 positron emission tomography measurements of blood flow in patients with intra-abdominal cancers.

Wells P, Jones T, Price P. Wells P, et al. Among authors: price p. Clin Cancer Res. 2003 Dec 15;9(17):6350-6. Clin Cancer Res. 2003. PMID: 14695134

7

2-[11C]thymidine positron emission tomography reproducibility in humans.

Wells P, Gunn RN, Steel C, Ranicar AS, Brady F, Osman S, Jones T, Price P. Wells P, et al. Among authors: price p. Clin Cancer Res. 2005 Jun 15;11(12):4341-7. doi: 10.1158/1078-0432.CCR-04-1818. Clin Cancer Res. 2005. PMID: 15958616 Free article.

8

New techniques in the pharmacokinetic analysis of cancer drugs. IV. Positron emission tomography.

Tilsley DW, Harte RJ, Jones T, Brady F, Luthra SK, Brown G, Price PM. Tilsley DW, et al. Among authors: price pm. Cancer Surv. 1993;17:425-42. Cancer Surv. 1993. PMID: 8137352 Review.

9

Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials.

Osman S, Luthra SK, Brady F, Hume SP, Brown G, Harte RJ, Matthews JC, Denny WA, Baguley BC, Jones T, Price PM. Osman S, et al. Among authors: price pm. Cancer Res. 1997 Jun 1;57(11):2172-80. Cancer Res. 1997. PMID: 9187117 Clinical Trial.

10

Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues.

Osman S, Rowlinson-Busza G, Luthra SK, Aboagye EO, Brown GD, Brady F, Myers R, Gamage SA, Denny WA, Baguley BC, Price PM. Osman S, et al. Among authors: price pm. Cancer Res. 2001 Apr 1;61(7):2935-44. Cancer Res. 2001. PMID: 11306471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,679 results

Search Page

Filters